{"id":"https://openalex.org/W7125809261","doi":"https://doi.org/10.1016/j.ero.2025.12.010","title":"Efficacy, safety, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab intravenously administered to adults with active rheumatoid arthritis and an inadequate response to methotrexate: a phase 3, randomised study","display_name":"Efficacy, safety, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab intravenously administered to adults with active rheumatoid arthritis and an inadequate response to methotrexate: a phase 3, randomised study","publication_year":2026,"publication_date":"2026-01-27","ids":{"openalex":"https://openalex.org/W7125809261","doi":"https://doi.org/10.1016/j.ero.2025.12.010","pmid":"https://pubmed.ncbi.nlm.nih.gov/42370118","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13292490"},"language":"en","primary_location":{"id":"doi:10.1016/j.ero.2025.12.010","doi":"https://doi.org/10.1016/j.ero.2025.12.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ero.2025.12.010","pdf_url":"https://ero.eular.org/article/S3050-7081(25)00136-3/pdf","source":{"id":"https://openalex.org/S5407047460","display_name":"EULAR Rheumatology Open","issn_l":"3050-7081","issn":["3050-7081"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EULAR Rheumatology Open","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ero.eular.org/article/S3050-7081(25)00136-3/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066282735","display_name":"Hiroaki Matsuno","orcid":"https://orcid.org/0000-0002-2195-5717","observed_orcids":["https://orcid.org/0000-0002-2195-5717"]},"institutions":[{"id":"https://openalex.org/I4210087594","display_name":"St. Luke's International Hospital","ror":"https://ror.org/002wydw38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087594"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroaki Matsuno","raw_affiliation_strings":["Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan","Matsuno Clinic for Rheumatic Disease, Toyama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4210087594"]},{"raw_affiliation_string":"Matsuno Clinic for Rheumatic Disease, Toyama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079748913","display_name":"Ernest Choy","orcid":"https://orcid.org/0000-0003-4459-8609","observed_orcids":["https://orcid.org/0000-0003-4459-8609"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Ernest Choy","raw_affiliation_strings":["Division of Infection and Immunity, CREATE Centre, Cardiff University, Cardiff, UK"],"raw_orcid":"https://orcid.org/0000-0003-4459-8609","affiliations":[{"raw_affiliation_string":"Division of Infection and Immunity, CREATE Centre, Cardiff University, Cardiff, UK","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018678002","display_name":"Paul Emery","orcid":"https://orcid.org/0000-0002-7429-8482","observed_orcids":["https://orcid.org/0000-0002-7429-8482","https://orcid.org/0000-0002-4136-3436"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]},{"id":"https://openalex.org/I2799390153","display_name":"Leeds Teaching Hospitals NHS Trust","ror":"https://ror.org/00v4dac24","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul Emery","raw_affiliation_strings":["Leeds NIHR Biomedical Research Centre, Leeds Teaching Hospitals Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leeds NIHR Biomedical Research Centre, Leeds Teaching Hospitals Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK","institution_ids":["https://openalex.org/I130828816","https://openalex.org/I2799390153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123932457","display_name":"Masato Okada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087594","display_name":"St. Luke's International Hospital","ror":"https://ror.org/002wydw38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087594"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masato Okada","raw_affiliation_strings":["Immuno-Rheumatology Centre, St. Luke's International Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Rheumatology Centre, St. Luke's International Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4210087594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124048900","display_name":"Roshan Dias","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2808169635","display_name":"Gedeon Richter (Hungary)","ror":"https://ror.org/0033rtn64","country_code":"HU","type":"company","lineage":["https://openalex.org/I2808169635"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Roshan Dias","raw_affiliation_strings":["Gedeon Richter Plc, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gedeon Richter Plc, Budapest, Hungary","institution_ids":["https://openalex.org/I2808169635"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081121405","display_name":"K\u00e1roly Horv\u00e1t-Karajz","orcid":"https://orcid.org/0009-0000-4446-397X","observed_orcids":["https://orcid.org/0009-0000-4446-397X"]},"institutions":[{"id":"https://openalex.org/I2808169635","display_name":"Gedeon Richter (Hungary)","ror":"https://ror.org/0033rtn64","country_code":"HU","type":"company","lineage":["https://openalex.org/I2808169635"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"K\u00e1roly Horv\u00e1t-Karajz","raw_affiliation_strings":["Gedeon Richter Plc, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gedeon Richter Plc, Budapest, Hungary","institution_ids":["https://openalex.org/I2808169635"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123968056","display_name":"Gordana Dancer","orcid":"https://orcid.org/0009-0005-0666-4937","observed_orcids":["https://orcid.org/0009-0005-0666-4937"]},"institutions":[{"id":"https://openalex.org/I2808169635","display_name":"Gedeon Richter (Hungary)","ror":"https://ror.org/0033rtn64","country_code":"HU","type":"company","lineage":["https://openalex.org/I2808169635"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Gordana Dancer","raw_affiliation_strings":["Gedeon Richter Plc, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gedeon Richter Plc, Budapest, Hungary","institution_ids":["https://openalex.org/I2808169635"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123985199","display_name":"Yusuke Karibe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165085132","display_name":"Mochida Pharmaceutical (Japan)","ror":"https://ror.org/045p8e908","country_code":"JP","type":"company","lineage":["https://openalex.org/I165085132"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yusuke Karibe","raw_affiliation_strings":["Mochida Pharmaceutical Co., Ltd, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mochida Pharmaceutical Co., Ltd, Tokyo, Japan","institution_ids":["https://openalex.org/I165085132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124037005","display_name":"Suguru Masuda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165085132","display_name":"Mochida Pharmaceutical (Japan)","ror":"https://ror.org/045p8e908","country_code":"JP","type":"company","lineage":["https://openalex.org/I165085132"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Suguru Masuda","raw_affiliation_strings":["Mochida Pharmaceutical Co., Ltd, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mochida Pharmaceutical Co., Ltd, Tokyo, Japan","institution_ids":["https://openalex.org/I165085132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072045920","display_name":"Joachim Kiefer","orcid":"https://orcid.org/0000-0002-3990-0917","observed_orcids":["https://orcid.org/0000-0002-3990-0917"]},"institutions":[{"id":"https://openalex.org/I2808169635","display_name":"Gedeon Richter (Hungary)","ror":"https://ror.org/0033rtn64","country_code":"HU","type":"company","lineage":["https://openalex.org/I2808169635"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Joachim Kiefer","raw_affiliation_strings":["Gedeon Richter Plc, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gedeon Richter Plc, Budapest, Hungary","institution_ids":["https://openalex.org/I2808169635"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076851275","display_name":"Gerd R\u00fcdiger Burmester","orcid":"https://orcid.org/0000-0001-7518-1131","observed_orcids":["https://orcid.org/0000-0001-7518-1131"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gerd R Burmester","raw_affiliation_strings":["Department of Rheumatology and Clinical Immunology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology and Clinical Immunology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5079748913"],"corresponding_institution_ids":["https://openalex.org/I79510175"],"apc_list":{"value":2080,"currency":"USD","value_usd":2080},"apc_paid":{"value":2080,"currency":"USD","value_usd":2080},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2","issue":"1","first_page":"155","last_page":"165"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tocilizumab","display_name":"tocilizumab","score":0.9440000057220459},{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9440000057220459},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/inadequate-response-to-methotrexate","display_name":"inadequate response to methotrexate","score":0.8820000290870667},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.5339999794960022},{"id":"https://openalex.org/keywords/das28-esr","display_name":"DAS28-ESR","score":0.8610000014305115},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.625},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.8949999809265137},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.7630000114440918},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.6800000071525574},{"id":"https://openalex.org/keywords/soluble-il-6-receptor","display_name":"soluble IL-6 receptor","score":0.8090000152587891},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.7059999704360962}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9283999800682068},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.8335000276565552},{"id":"https://openalex.org/C2777178219","wikidata":"https://www.wikidata.org/wiki/Q425154","display_name":"Tocilizumab","level":3,"score":0.8070999979972839},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.7609999775886536},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.7088000178337097},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5738999843597412},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3833000063896179},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3547999858856201},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3400000035762787},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3172000050544739},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.296099990606308},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.2937999963760376},{"id":"https://openalex.org/C2908701176","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biological drugs","level":3,"score":0.2872999906539917},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2849999964237213},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2727000117301941},{"id":"https://openalex.org/C3018913218","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody response","level":3,"score":0.25699999928474426},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.2526000142097473},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2506999969482422}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1016/j.ero.2025.12.010","doi":"https://doi.org/10.1016/j.ero.2025.12.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ero.2025.12.010","pdf_url":"https://ero.eular.org/article/S3050-7081(25)00136-3/pdf","source":{"id":"https://openalex.org/S5407047460","display_name":"EULAR Rheumatology Open","issn_l":"3050-7081","issn":["3050-7081"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EULAR Rheumatology Open","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13292490","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13292490/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13292490/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EULAR Rheumatol Open","raw_type":"Text"},{"id":"pmid:42370118","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42370118","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EULAR rheumatology open","raw_type":"Journal Article"},{"id":"pmh:oai:https://orca.cardiff.ac.uk:185986","doi":null,"is_oa":true,"landing_page_url":"https://orca.cardiff.ac.uk/id/eprint/185986/1/PIIS3050708125001363.pdf","pdf_url":"https://orca.cardiff.ac.uk/id/eprint/185986/1/PIIS3050708125001363.pdf","source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:doaj.org/article:c18b472773b8430ca05f7e7091929ec6","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c18b472773b8430ca05f7e7091929ec6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"EULAR Rheumatology Open, Vol 2, Iss 1, Pp 155-165 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.ero.2025.12.010","doi":"https://doi.org/10.1016/j.ero.2025.12.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ero.2025.12.010","pdf_url":"https://ero.eular.org/article/S3050-7081(25)00136-3/pdf","source":{"id":"https://openalex.org/S5407047460","display_name":"EULAR Rheumatology Open","issn_l":"3050-7081","issn":["3050-7081"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EULAR Rheumatology Open","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321863","display_name":"Gedeon Richter","ror":"https://ror.org/0033rtn64"},{"id":"https://openalex.org/F7382079405","display_name":"Gedeon Richter","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7125809261.pdf","grobid_xml":"https://content.openalex.org/works/W7125809261.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W90561351","https://openalex.org/W1608734376","https://openalex.org/W2017715569","https://openalex.org/W2023761225","https://openalex.org/W2031432627","https://openalex.org/W2097405167","https://openalex.org/W2118561596","https://openalex.org/W2146977789","https://openalex.org/W2149929102","https://openalex.org/W2169537705","https://openalex.org/W2171581427","https://openalex.org/W2177530838","https://openalex.org/W2227181458","https://openalex.org/W2342464058","https://openalex.org/W2381025878","https://openalex.org/W2564951324","https://openalex.org/W2570070838","https://openalex.org/W2588687669","https://openalex.org/W2623521568","https://openalex.org/W2625653094","https://openalex.org/W2765166506","https://openalex.org/W2780872292","https://openalex.org/W2894977001","https://openalex.org/W2905076420","https://openalex.org/W2939394019","https://openalex.org/W2947562759","https://openalex.org/W3017957088","https://openalex.org/W3044289975","https://openalex.org/W3107028140","https://openalex.org/W3112344668","https://openalex.org/W3182578576","https://openalex.org/W4280592341","https://openalex.org/W4312129003","https://openalex.org/W4378347895","https://openalex.org/W4386305354","https://openalex.org/W4388867365","https://openalex.org/W4393318617","https://openalex.org/W4393347603","https://openalex.org/W4402334920","https://openalex.org/W4403533442","https://openalex.org/W4405394714","https://openalex.org/W4405994133","https://openalex.org/W4406333921","https://openalex.org/W4410484245","https://openalex.org/W4411410199","https://openalex.org/W4412837467","https://openalex.org/W7083310537"],"related_works":["https://openalex.org/W4411394543","https://openalex.org/W7171839896","https://openalex.org/W4402334920","https://openalex.org/W4391543457","https://openalex.org/W4389886027","https://openalex.org/W7160629940","https://openalex.org/W7165120978","https://openalex.org/W4395111741","https://openalex.org/W4412362734","https://openalex.org/W4379650204"],"abstract_inverted_index":{"Objectives:":[0],"This":[1,239],"phase":[2],"3":[3],"study":[4,240],"(jRCT2031220512)":[5],"evaluated":[6,53],"the":[7,13,67,90,95,102,144,167],"equivalence":[8,87,104,168],"in":[9,26,73,146,235],"efficacy,":[10,243],"and":[11,18,24,57,121,174,193,217,229,244,247,251],"compared":[12],"serum":[14,116,175],"concentration,":[15,118],"pharmacodynamics,":[16,119],"safety,":[17,120],"immunogenicity":[19],"of":[20,42,213,226,249],"proposed":[21],"biosimilar":[22],"RGB-19":[23,45,250],"tocilizumab":[25,47,137,156,253],"adults":[27],"with":[28,51,81,86,209,256],"active":[29,257],"rheumatoid":[30],"arthritis":[31],"(RA).":[32],"Methods:":[33],"Participants":[34],"were":[35,112,128,179,198,207],"randomly":[36,129],"assigned":[37,130],"1:1":[38],"to":[39,54,60,131,184,202,221],"intravenous":[40],"infusions":[41],"8":[43],"mg/kg":[44],"or":[46],"every":[48],"4":[49],"weeks,":[50],"efficacy":[52,114,172],"week":[55,61,108,142,185,203,222],"52":[56],"safety":[58,246],"follow-up":[59],"54.":[62,223],"The":[63,224],"primary":[64],"endpoint":[65],"was":[66,100,160,232],"mean":[68,147],"change":[69],"from":[70],"baseline":[71],"(CfB)":[72],"Disease":[74],"Activity":[75],"Score":[76],"based":[77],"on":[78],"28":[79],"joints":[80],"erythrocyte":[82],"sedimentation":[83],"rate":[84],"(DAS28-ESR),":[85],"determined":[88],"if":[89],"2-sided":[91],"95%":[92],"CI":[93],"for":[94,254],"pooled":[96],"difference":[97,145],"between":[98,150,181,200],"groups":[99,151,182,201],"within":[101,166],"predefined":[103],"margin":[105],"(\u00b10.6":[106],"at":[107],"12).":[109],"Secondary":[110],"objectives":[111],"other":[113,171],"indicators,":[115],"drug":[117,176,219],"immunogenicity.":[122],"Results:":[123],"In":[124],"total,":[125],"368":[126],"participants":[127,255],"treatment":[132],"(RGB-19":[133,152],"N":[134,138],"=":[135,139,154,158],"182;":[136],"186).":[140],"At":[141],"12,":[143],"DAS28-ESR":[148],"CfB":[149],"n":[153,157],"173;":[155],"181)":[159],"-0.21":[161],"(95%":[162],"CI:":[163],"-0.43,":[164],"0.02;":[165],"margin).":[169],"All":[170],"indicators":[173],"concentration":[177],"values":[178,197],"similar":[180,199,211,245],"up":[183],"52.":[186,204],"Median":[187],"absolute":[188],"neutrophil":[189],"count,":[190],"C-reactive":[191],"protein,":[192],"soluble":[194],"interleukin-6":[195],"receptor":[196],"Safety":[205],"profiles":[206],"similar,":[208],"a":[210],"incidence":[212,225],"treatment-emergent":[214,227],"adverse":[215,218],"events":[216],"reactions":[220],"antidrug":[228],"neutralising":[230],"antibodies":[231],"similarly":[233],"low":[234],"both":[236],"groups.":[237],"Conclusions:":[238],"demonstrated":[241],"equivalent":[242],"immunogenicity,":[248],"reference":[252],"RA.":[258]},"counts_by_year":[],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2026-01-28T00:00:00"}